7:11 AM ET, 07/10/2023 - MT Newswires
07:11 AM EDT, 07/10/2023 (MT Newswires) -- ShockWave Medical (SWAV) received an investment rating upgrade on Monday to overweight from equalweight from Morgan Stanley, which said it expects a "solid improvement in reimbursement" for the medical technology company's intravascular lithotripsy treatment of atherosclerotic cardiovascular disease to result in Street growth expectations for 2024-2025 being "too low."
Morgan Stanley also raised its price target on ShockWave Medical's shares to $335 each from $291. This moves the target farther above the stock's Friday closing price of $261.77.
The upgrade comes as Morgan Stanley expects the US Centers for Medicare & Medicaid Services to propose "better outpatient reimbursement in the coming week ( my emphasis )" for ShockWave Medical's intravascular lithotripsy, or IVL. This technology uses sonic pressure waves to disrupt challenging calcified plaque.
Improved outpatient reimbursement would drive "a potential acceleration in penetration of SWAV's coronary IVL catheter and upside to Street expectations," Morgan Stanley's analysts said in a Monday note to clients.
Morgan Stanley also sees ShockWave Medical's short-term numbers as "encouraging," and highlighted that competition doesn't appear to be coming "anytime soon." Abbott (ABT) is also working on intravascular lithotripsy but Morgan Stanley's analysts noted Abbott's first-in-human trials have yet to begin and there are "no other clear peers in the market," the analysts noted.
ShockWave Medical has an average investment rating of outperform among analysts polled by Capital IQ, with price targets ranging from $165 to $335.
(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contact-us)
Price: 270.21, Change: +8.44, Percent Change: +3.22
--------------------
Kiwi
Recent SWAV News
- Kuehn Law Encourages SWAV, ALE, PRFT, and LSAK Investors to Contact Law Firm • PR Newswire (US) • 05/08/2024 07:12:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/06/2024 08:14:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/06/2024 08:05:20 PM
- Shockwave Medical Reports First Quarter 2024 Financial Results • GlobeNewswire Inc. • 05/06/2024 08:05:00 PM
- Shockwave Reducer Demonstrates Consistent, Positive Results in ‘Real-World’ Study • GlobeNewswire Inc. • 04/08/2024 08:03:00 PM
- Rowley Law PLLC is Investigating Proposed Acquisition of Shockwave Medical, Inc. • PR Newswire (US) • 04/05/2024 06:55:00 PM
- Kuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to Contact Law Firm • PR Newswire (US) • 04/05/2024 05:09:00 PM
- Johnson & Johnson to Acquire Shockwave Medical • Business Wire • 04/05/2024 10:31:00 AM
- GameStop Shares Tumble 20% in Pre-Market Trading Amid Revenue Decline, Direct Digital Plummets 42%, and More News • IH Market News • 03/27/2024 10:54:47 AM
- Shockwave Medical to Participate in the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 03/26/2024 12:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/07/2024 02:10:29 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 03/06/2024 09:24:32 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/01/2024 10:09:57 PM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/26/2024 09:27:05 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/26/2024 09:06:34 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/23/2024 10:56:40 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/23/2024 01:13:28 AM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/22/2024 09:24:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/22/2024 01:55:36 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/15/2024 09:03:36 PM
- Shockwave Medical Reports Fourth Quarter and Full Year 2023 Financial Results • GlobeNewswire Inc. • 02/15/2024 09:03:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/08/2024 01:17:11 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:18:39 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:14:59 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/07/2024 01:11:50 AM
VAYK Discloses Strategic Conversation on Potential Acquisition of $4 Million Home Service Business • VAYK • May 9, 2024 9:00 AM
Bantec's Howco Awarded $4.19 Million Dollar U.S. Department of Defense Contract • BANT • May 8, 2024 10:00 AM
Element79 Gold Corp Successfully Closes Maverick Springs Option Agreement • ELEM • May 8, 2024 9:05 AM
Kona Gold Beverages, Inc. Achieves April Revenues Exceeding $586,000 • KGKG • May 8, 2024 8:30 AM
Epazz plans to spin off Galaxy Batteries Inc. • EPAZ • May 8, 2024 7:05 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM